{"brief_title": "Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis", "brief_summary": "The purpose of this research study is to evaluate the safety, tolerability, and efficacy of Interferon gamma-1b (IFN-gamma 1b) when administered by subcutaneous injection over a period of 4 weeks to patients with mild-to-moderate cystic fibrosis. Additionally, preliminary assessments on the effects of IFN-gamma 1b on lung function and other indicators of health will be made.", "condition": "Cystic Fibrosis", "intervention_type": "Drug", "intervention_name": "interferon gamma-1b", "description": "100 or 200 mcg, SQ, 3x per week", "criteria": "- At least 6 years of age - Diagnosis of cystic fibrosis (against certain criteria) - Able to perform pulmonary (lung) function tests and participate in induced sputum procedures - Pulmonary function values must meet certain minimal requirements - Must have acceptable laboratory test results - Cannot be on certain medications during and immediately prior to study - Cannot have a history of unstable or deteriorating cardiac or neurologic disease", "gender": "All", "minimum_age": "6 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00043342.xml"}